Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,470 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance.
Kabe Y, Nakane T, Koike I, Yamamoto T, Sugiura Y, Harada E, Sugase K, Shimamura T, Ohmura M, Muraoka K, Yamamoto A, Uchida T, Iwata S, Yamaguchi Y, Krayukhina E, Noda M, Handa H, Ishimori K, Uchiyama S, Kobayashi T, Suematsu M. Kabe Y, et al. Among authors: yamamoto a, yamamoto t. Nat Commun. 2016 Mar 18;7:11030. doi: 10.1038/ncomms11030. Nat Commun. 2016. PMID: 26988023 Free PMC article.
Efficacy of Second-line Nivolumab Versus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases.
Yamamichi G, Kato T, Yoshimura A, Tani M, Horibe Y, Liu Y, Sassi N, Okuda Y, Oka T, Uemura T, Yamamoto A, Ishizuya YU, Hayashi T, Yamamoto Y, Hatano K, Kawashima A, Takao T, Nishimura K, Takada S, Tsujihata M, Nonomura N. Yamamichi G, et al. Among authors: yamamoto a. Anticancer Res. 2025 Feb;45(2):639-650. doi: 10.21873/anticanres.17451. Anticancer Res. 2025. PMID: 39890197
Effects of intermittently scanned continuous glucose monitoring on body weight and glycemic variability in overweight individuals with impaired glucose tolerance or mild diabetes: A pilot randomized controlled trial.
Nishikage S, Nakagawa Y, Hirota Y, Yoshimura K, Ueda M, Yamamoto A, Takayoshi T, Matsuoka A, Takahashi M, Takeda A, Yokota K, Nakamura T, Sakaguchi K, Ogawa W. Nishikage S, et al. Among authors: yamamoto a. Obes Res Clin Pract. 2025 Jan 30:S1871-403X(25)00014-6. doi: 10.1016/j.orcp.2025.01.008. Online ahead of print. Obes Res Clin Pract. 2025. PMID: 39884899
4,470 results